Literatura académica sobre el tema "Matrix Metalloproteinase 2 (MMP2)"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Matrix Metalloproteinase 2 (MMP2)".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Matrix Metalloproteinase 2 (MMP2)"
Balasa, Rodica, Ciurba Bianca, Voidezan Septimiu, Simu Iunius, Hutanu Adina, Andone Sebastian, Romaniuc Andreea, Motataianu Anca y Maier Smaranda. "The Matrix Metalloproteinases Panel in Multiple Sclerosis Patients Treated with Natalizumab: A Possible Answer to Natalizumab Non- Responders". CNS & Neurological Disorders - Drug Targets 17, n.º 6 (28 de agosto de 2018): 464–72. http://dx.doi.org/10.2174/1871527317666180703102536.
Texto completoBartnykaitė, Agnė, Aistė Savukaitytė, Justina Bekampytė, Rasa Ugenskienė, Danguolė Laukaitienė, Erika Korobeinikova, Jurgita Gudaitienė y Elona Juozaitytė. "The Role of Matrix Metalloproteinase Single-Nucleotide Polymorphisms in the Clinicopathological Properties of Breast Cancer". Biomedicines 10, n.º 8 (4 de agosto de 2022): 1891. http://dx.doi.org/10.3390/biomedicines10081891.
Texto completoYang, Hui, Carlos E. Bueso-Ramos, Sherry A. Pierce, Yue Wei, Zhihong Fang, Martin Nguyen, Michael Fernadez, Marylou Cardenas-Turanzas, Hagop M. Kantarjian y Guillermo Garcia-Manero. "Expression Profiles of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinases (TIMPs) in Myelodysplastic Syndromes (MDS): Level of MMP-9 Is Associated with Improved Prognosis in MDS Patients". Blood 120, n.º 21 (16 de noviembre de 2012): 3845. http://dx.doi.org/10.1182/blood.v120.21.3845.3845.
Texto completoCoven, İlker, Ozge Ozer, Ozlem Ozen, Feride İffet Şahin y Nur Altinors. "Presence of matrix metalloproteinase–2 and tissue inhibitor matrix metalloproteinase–2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas". Journal of Neurosurgery 121, n.º 6 (diciembre de 2014): 1478–82. http://dx.doi.org/10.3171/2014.8.jns13515.
Texto completoWIPFF, JULIEN, PHILIPPE DIEUDE, JEROME AVOUAC, KIET TIEV, ERIC HACHULLA, JEAN-LUC CRACOWSKI, ELIZABETH DIOT et al. "Association of Metalloproteinase Gene Polymorphisms with Systemic Sclerosis in the European Caucasian Population". Journal of Rheumatology 37, n.º 3 (28 de enero de 2010): 599–602. http://dx.doi.org/10.3899/jrheum.090973.
Texto completoDetry, Benoit, Charlotte Erpicum, Jenny Paupert, Silvia Blacher, Catherine Maillard, Françoise Bruyère, Hélène Pendeville et al. "Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase". Blood 119, n.º 21 (24 de mayo de 2012): 5048–56. http://dx.doi.org/10.1182/blood-2011-12-400267.
Texto completoRen, Xiaoyu, Graham D. Lamb y Robyn M. Murphy. "Distribution and activation of matrix metalloproteinase-2 in skeletal muscle fibers". American Journal of Physiology-Cell Physiology 317, n.º 3 (1 de septiembre de 2019): C613—C625. http://dx.doi.org/10.1152/ajpcell.00113.2019.
Texto completoSultan, Baqur A. y Raad Ajam Sayhel Al.Jorany. "Evaluation of Matrix Metalloproteinase-2 (MMP2) in Aborted Women Infected with Toxoplasma gondii." Kufa Journal for Nursing Sciences 6, n.º 2 (29 de agosto de 2016): 122–29. http://dx.doi.org/10.36321/kjns.vi20162.2704.
Texto completoKan, Taichi, Hiromi Ueda, Taishi Takahara, Yoshimasa Tsuchiya, Mayuko Kishimoto, Yasue Uchida, Tetsuya Ogawa, Wataru Ohashi, Toyonori Tsuzuki y Yasushi Fujimoto. "Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma". BioMed Research International 2021 (10 de marzo de 2021): 1–8. http://dx.doi.org/10.1155/2021/6644897.
Texto completoZhang, Jianmei, Mi-Yeon Kim y Jae Youl Cho. "Euodia pasteuriana Methanol Extract Exerts Anti-Inflammatory Effects by Targeting TAK1 in the AP-1 Signaling Pathway". Molecules 25, n.º 23 (7 de diciembre de 2020): 5760. http://dx.doi.org/10.3390/molecules25235760.
Texto completoTesis sobre el tema "Matrix Metalloproteinase 2 (MMP2)"
Teh, Elaine. "Matrix metalloproteinase-2 (MMP2) and myocardial dysfunction associated with urgent cardiac surgery". Thesis, King's College London (University of London), 2013. https://kclpure.kcl.ac.uk/portal/en/theses/matrix-metalloproteinase2-mmp2-and-myocardial-dysfunction-associated-with-urgent-cardiac-surgery(de82119f-7ae0-4131-a743-03a8d168b62a).html.
Texto completoKuittinen, O. (Outi). "Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in hematological malignancies". Doctoral thesis, University of Oulu, 2003. http://urn.fi/urn:isbn:951426942X.
Texto completoCoughlan, Andrew Richard. "Matrix metalloproteinase (MMP) 2 and 9 in canine arthritis". Thesis, University of Liverpool, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.243201.
Texto completoGuo, Chung. "Divergent regulation of MMP-2 secretion and activation in adult rat cardiac fibroblasts". Thesis, De Montfort University, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.247642.
Texto completoBergman, Robert Loring. "Matrix Metalloproteinases 2 and 9 in Normal Canine Cerebrospinal Fluid". Thesis, Virginia Tech, 2001. http://hdl.handle.net/10919/33750.
Texto completoMaster of Science
Renaud, Virginie. "Étude de la voie de présentation de l'antigène MMP-2 par les cellules tumorales". Nantes, 2009. http://www.theses.fr/2009NANT2099.
Texto completoFrom a patient still melanoma free after TIL injection, we characterized a new tumor antigen, MMP-2, recognized by a CD8 T cell clone in HLA-A*0201 context. Surprisingly melanoma cell lines present this tumor antigen by the cross presentation pathway (Godefroy & al. , 2005). In the first part, we wondered if disulfide bonds present in MMP-2 were not responsible for its absence of presentation by the endogenous pathway. By mutagenesis, we replaced a cystein by an alanine in the cDNA coding for MMP-2, in order to induce a disulfide bond deletion and then we transfected these cDNA mutants in COS-7 and human tumor cell lines. We showed that MMP-2 deletion of one disulfide bond induce its presentation by the endogenous pathway. By pulse chase experiments we also demonstrated that MMP-2 mutated form is more rapidly degraded than the wild form. MMP-2 folding and consequently conformation seems to play an important role in the absence of its presentation by the classical pathway. In the second part, we try to determine intracellular pathway implicated in MMP-2 cross-presentation in melanoma cells. Indeed, after secretion, MMP-2 is internalized by melanoma cells in an v3 dependent manner and by an unknown pathway. MMP-2 is finally processed by the proteasome and loaded on MHC class I molecule (Godefroy & al. , 2005). By using drugs, we determined that MMP-2 cross-presentation involves the retrotranslocation machinery, the proteasome and TAP, all implicated in the endogenous pathway. To determine compartments necessary to MMP-2 cross-presentation we tested Organelles lights (Invitrogen). These reagents provide a method for targeted specific subcellular structures within living cells
Kuntze, Luciana Bärg. "Efeito inibitório do captopril sobre a Metaloproteinase-2 da Matriz Extracelular (MMP-2) in vitro". Universidade de São Paulo, 2012. http://www.teses.usp.br/teses/disponiveis/17/17133/tde-27072016-160209/.
Texto completoMMP-2 is involved in many physiological and pathological processes. This protease shares structural similarities with the angiotensin-converting enzyme (ACE), and ACE inhibitors have been described to inhibit MMP-2. However, this inhibitory potential has not been tested using a highly purified MM-2 so far. This study aimed at investigating the inhibitory potential of captopril on MMP-2 activity. First it was tested whether the dissolution of captopril would induce changes in the pH of the solutions. Secondly, the direct inhibitory effect of captopril on plasma MMP-2 and on a recombinant human MMP-2 (rhMMP-2) produced and purified from E. coli was tested. The in vitro activity assays included gelatin zymography and a fluorimetric assay with DQ gelatin. Captopril solubilization significantly decreased the pH of the 50 mM Tris buffer solution (p<0.01) but did not decreased the pH of the 200 mM Tris Buffer solution (p>0.05). Zymography results of plasma and rhMMP-2 showed that inhibition of the activity only reached statistical significance >= 4 and 1 mM of captopril, respectively (p<0,05). The presence of captopril in the fluorimetric assay resulted in a significant inhibition of the rhMMP-2 activity only at concentrations >= 2 mM (p<0.01), whereas APMA-activated rhMMP-2 was inhibited by 0.5 mM of captopril (p<0.01). The captopril concentrations found to inhibit MMP-2 are several times of magnitude higher than the maximum plasma concentration after a dose of 50 mg of captopril. In conclusion, captopril does not seem to cause significant inhibition of MMP-2 in the concentrations found in vivo, and more attention has to be given to the pH of the solutions when testing protease inhibition in vitro.
Vasala, K. (Kaija). "Matrix metalloproteinase MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in bladder carcinoma". Doctoral thesis, University of Oulu, 2008. http://urn.fi/urn:isbn:9789514288746.
Texto completoKim, Yu Shin. "Correlation Between MMP-2 and -9 Levels and Local Stresses in Arteries Using a Heterogeneous Mechanical Model". Diss., Georgia Institute of Technology, 2007. http://hdl.handle.net/1853/16134.
Texto completoFarooqi, Owais Ali. "Effect of methamphetamine on gingival fibroblast production of matrix metalloproteinase (MMP)-2 and -9 and tissue inhibitor of metalloproteinase (TIMP)-1 and -2 in vitro". View the abstract Download the full-text PDF version, 2009. http://etd.utmem.edu/ABSTRACTS/2009-023-Farooqi-index.htm.
Texto completoTitle from title page screen (viewed on August 5, 2009). Research advisor: David A. Tipton, D.D.S., Ph.D. Document formatted into pages (vi, 39 p. : ill.). Vita. Abstract. Includes bibliographical references (p. 27-38).
Libros sobre el tema "Matrix Metalloproteinase 2 (MMP2)"
Yeung, Oliver. Differential regulation of matrix metalloproteinase-2 (MMP-2) by phorbol myrisate acetate, and by DL-[alpha]-difluoromethylornithine, in cell lines of varying tumorigenic and metastatic potential. Ottawa: National Library of Canada, 1999.
Buscar texto completoBaragwanath, Philip. Matrix metalloproteinase-2 and -9 in human wound healing. Birmingham: University of Birmingham, 2000.
Buscar texto completoCapítulos de libros sobre el tema "Matrix Metalloproteinase 2 (MMP2)"
Salajegheh, Ali. "Matrix Metalloproteinase 2 (MMP2)". En Angiogenesis in Health, Disease and Malignancy, 203–8. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-28140-7_31.
Texto completoHinterseher, I., D. Krex, D. Ockert, E. Kuhlisch, H. K. Schackert y H. D. Saeger. "Analyse des Matrix Metalloproteinase-2 Genes (MMP-2) als ätiologischer Faktor spontaner Aortenaneurysmen". En Zurück in die Zukunft, 460–61. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-55611-1_280.
Texto completoHinterseher, Irene, D. Krex, D. Ockert, E. Kuhlisch, H. K. Schackert y H. D. Saeger. "Genomische Analyse des Matrix Metalloproteinase-2 Gens (MMP-2) als potentieller ätiologischer Faktor spontaner Aortenaneurysmen". En Deutsche Gesellschaft für Chirurgie, 549–50. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-19024-7_151.
Texto completoSienel, W., R. Seen-Hibler, W. Wöckel, O. Thetter, W. Mutschler y B. Passlick. "Die Überexpression von Matrix Metalloproteinase 2 (MMP-2) ist mit einer Frühdisseminierung bei operablem Adenokarzinom der Lunge assoziiert". En Deutsche Gesellschaft für Chirurgie, 93–95. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-56698-1_24.
Texto completoLopes Barreto, Deirisa y Raymond T. Krediet. "Matrix Metalloproteinase-2 (MMP-2) and Plasminogen Activator Inhibitor-1 (PAI-1) in Peritoneal Dialysis: Biological Implications and Clinical Utility". En Biomarkers in Kidney Disease, 911–30. Dordrecht: Springer Netherlands, 2016. http://dx.doi.org/10.1007/978-94-007-7699-9_25.
Texto completoLopes Barreto, Deirisa y Raymond T. Krediet. "Matrix Metalloproteinase-2 (MMP-2) and Plasminogen Activator Inhibitor-1 (PAI-1) in Peritoneal Dialysis: Biological Implications and Clinical Utility". En Biomarkers in Kidney Disease, 1–20. Dordrecht: Springer Netherlands, 2015. http://dx.doi.org/10.1007/978-94-007-7743-9_25-1.
Texto completoChan, Brandon Y. H., Andrej Roczkowsky, Ramses Ilarraza y Richard Schulz. "Matrix Metalloproteinase-2". En Encyclopedia of Signaling Molecules, 2996–3005. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-67199-4_101708.
Texto completoChan, Brandon Y. H., Andrej Roczkowsky, Ramses Ilarraza y Richard Schulz. "Matrix Metalloproteinase-2". En Encyclopedia of Signaling Molecules, 1–10. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4614-6438-9_101708-1.
Texto completoTyagi, Suresh C., Larry Meyer, Richard A. Schmaltz, Hanumanth K. Reddy y Donald J. Voelker. "Proteinases and Restenosis: Matrix Metalloproteinase and their Inhibitor and Activator". En Cardiovascular Disease 2, 19–30. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-1959-1_3.
Texto completoKalev-Altman, Rotem, Efrat Monsonego-Ornan y Dalit Sela-Donenfeld. "The Role of Matrix Metalloproteinase-2 and Metalloproteinase-9 in Embryonic Neural Crest Cells and Their Derivatives". En Proteases in Physiology and Pathology, 27–48. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-2513-6_2.
Texto completoActas de conferencias sobre el tema "Matrix Metalloproteinase 2 (MMP2)"
Dutta, Anindita, Jing Li, Huimin Lu, Jacqueline Akech, Jitesh Pratap, Tao Wang, Thomas J. FitzGerald et al. "Abstract C40: αvβ6 integrin promotes a TGFβ1-mediated cancer cell autonomous osteolytic program through upregulation of matrix metalloproteinase 2 (MMP2)". En Abstracts: AACR Special Conference on Tumor Invasion and Metastasis - January 20-23, 2013; San Diego, CA. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.tim2013-c40.
Texto completoRevilla Lopez, E. M., M. Boada, V. Ruiz De Miguel, S. Gomez Ollés y B. Saez. "Exploring the role of matrix metalloproteinase 2 (MMP-2) as a biomarker in lymphangioleiomyomatosis". En ERS International Congress 2022 abstracts. European Respiratory Society, 2022. http://dx.doi.org/10.1183/13993003.congress-2022.144.
Texto completoPitchford, Simon C., Stefania Momi, Clive P. Page y Paolo Gresele. "The Role Of Platelet Matrix-Metalloproteinase 2 (MMP2) On Platelet And Leukocyte Migration Through Lung Tissue In A Murine Model Of Allergic Inflammation". En American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2784.
Texto completoStott-Miller, Marni, John Houck, Pawadee Lohavanichbutr, Stephen M. Schwartz, Melissa P. Upton y Chu Chen. "Abstract 3819: Matrix metalloproteinase-1 (MMP1) is an important marker of oral squamous cell carcinoma". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-3819.
Texto completoMudiyanselage, Chandana S. K. Herath, Neil Mitra, Dasuni Niyagama Gamage, Hiromichi Miyagaki, Abhinit Shah, Xiaohong Yan, Vesna Cekic y Richard L. Whelan. "Abstract 1145: Assessing the diagnostic value of the combination of Matrix Metalloproteinase 2 (MMP2) and Progranulin (PGRN) preoperative plasma levels for colorectal cancer (CRC)". En Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-1145.
Texto completoSeccareccia, Erica, Shun Li y Pnina Brodt. "Abstract 5255: The role of IGF1 signaling in site specific tumor metastasis: Regulating matrix metalloproteinase (MMP) expression". En Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-5255.
Texto completoSong, Nan, Hyuna Sung, Sujee Jeon, Yunhee Lee, Ji-Yeob Choi, Sue K. Park, Kyoung-Mu Lee et al. "Abstract 4494: Preoperative serum levels of matrix metalloproteinase-2 (MMP-2) and survival of breast cancer among Korean women". En Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-4494.
Texto completoNg, Ho Yin, Brian G. Oliver, Janette K. Burgess, Vera P. Krymskaya, Judith L. Black y Lyn M. Moir. "Inhibition Of Matrix Metalloproteinase-2 (MMP-2) Decreases Migration Of TSC2-Null Mouse Embryonic Fibroblasts – Relevance To Pulmonary Lymphangioleiomyomatosis (LAM)". En American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3662.
Texto completoIto, Yusuke, Hitoshi Ishiguro, Naohito Kobayashi, Hisashi Hasumi, Masatoshi Watanabe, Masahiro Yao y Hiroji Uemura. "Abstract 435: Adipocyte-derived monocyte chemotactic protein-1 (MCP-1) promotes prostate cancer progression through matrix metalloproteinase (MMP-2) mediated extracellular matrix degradation". En Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-435.
Texto completoWang, Ying, John A. Johnson, Abigail Fulp, Michael A. Sutton y Susan M. Lessner. "Adhesive Strength of Atherosclerotic Plaques Depends on Collagen Content". En ASME 2012 Summer Bioengineering Conference. American Society of Mechanical Engineers, 2012. http://dx.doi.org/10.1115/sbc2012-80433.
Texto completoInformes sobre el tema "Matrix Metalloproteinase 2 (MMP2)"
Hernandez-Barrantes, Sonia y Rafael Fridman. Extracellular Matrix Regulations of Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) and Matrix Metalloproteinase-2 (MMP-2) in Human Breast Fibroblasts. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2002. http://dx.doi.org/10.21236/ada413613.
Texto completoHernandez-Barrantes, Sonia y Rafael Fridman. Extracellular Matrix Regulations of Membrane Type 1-Matrix Metalloproteinasis (MT1-MMP) and Matrix Metalloproteinase-2 (MMP-2) in Human Breast Fibroblasts. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2000. http://dx.doi.org/10.21236/ada395355.
Texto completoHarnandez-Barrantes, Sonia y Rafael Fridman. Extracellular Matrix Regulations of Membrane Type 1 - Matrix Metalloproteinasis (MT1-MMP) and Matrix Metalloproteinase-2 (MMP-2) in Human Breast Fibroblasts. Fort Belvoir, VA: Defense Technical Information Center, agosto de 2001. http://dx.doi.org/10.21236/ada396694.
Texto completoSamah, Nazirah, Azizah Ugusman, Adila A. Hamid, Nadiah Sulaiman y Amilia Aminuddin. Role of matrix metalloproteinase-2 among coronary artery disease (CAD) patients: A systematic review. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, abril de 2023. http://dx.doi.org/10.37766/inplasy2023.4.0058.
Texto completo